The Study on Prognosis in Patients with Adenoid Cystic Carcinoma of the External Auditory Canal.

IF 1 4区 医学 Q3 OTORHINOLARYNGOLOGY
Ying Wang, Li Xu, Bing Guan, Tongtong Tian, Lingmei Chang
{"title":"The Study on Prognosis in Patients with Adenoid Cystic Carcinoma of the External Auditory Canal.","authors":"Ying Wang,&nbsp;Li Xu,&nbsp;Bing Guan,&nbsp;Tongtong Tian,&nbsp;Lingmei Chang","doi":"10.5152/iao.2023.22850","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Adenoid cystic carcinoma of the external auditory canal is a rare primary malignancy, and surgery is the primary management strategy. This study aims to optimize management strategies and improve prognosis of adenoid cystic carcinoma of the external auditory canal.</p><p><strong>Methods: </strong>Seventeen patients with adenoid cystic carcinoma of external auditory canal who had been admitted to a single institution from January 2008 to March 2019 were recruited and retrospectively reviewed. Among patients with T1 tumors, 2 underwent local external auditory canal resection, 1 received lateral temporal bone resection+superficial parotidectomy. Among patients with T2 tumors, all 5 patients underwent lateral temporal bone resection+superficial parotidectomy. Among patients with T3 tumors, 3 underwent subtotal temporal bone resection+superficial parotidectomy, 2 underwent subtotal temporal bone resection+superficial parotidectomy+radiotherapy, and 1 underwent extended temporal bone resection+superficial parotidectomy+radiotherapy. Among patients with T4 tumors, 2 underwent subtotal temporal bone resection+superficial parotidectomy and 1 underwent extended temporal bone resection+total parotidectomy+radiotherapy.</p><p><strong>Results: </strong>The common manifestations included otalgia (82.4%), hearing loss (23.5%), external auditory canal mass (23.5%), otorrhea (17.6%), and aural fullness (5.9%). In the study, 5/17 (29.4%) patients had been misdiagnosed preoperatively, 5/17 (29.4%) patients revealed local recurrence, and 3/17 patients (17.6%) were identified with distant metastasis postoperatively. The 3- and 5-year overall survival rates were 88.2% and 82.3%, respectively. There was no significant difference in overall survival (P=.746) and disease-free survival (P=.933) between patients receiving different surgical approaches. Three out of 17 patients (17.6%) died of T2, T3, and T4 diseases, respectively.</p><p><strong>Conclusion: </strong>Otalgia is the most common manifestation of adenoid cystic carcinoma of the external auditory canal, and misdiagnosis is frequently encountered. Surgery is the preferred therapy, and local resection is associated with relapse, lateral temporal bone resection is strongly recommended in patients with early-stage tumor. Regular follow-up should be routinely conducted postoperatively to early identify local recurrence.</p>","PeriodicalId":54793,"journal":{"name":"Journal of International Advanced Otology","volume":"19 2","pages":"149-154"},"PeriodicalIF":1.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/60/34/jiao-19-2-149.PMC10152106.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of International Advanced Otology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5152/iao.2023.22850","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Adenoid cystic carcinoma of the external auditory canal is a rare primary malignancy, and surgery is the primary management strategy. This study aims to optimize management strategies and improve prognosis of adenoid cystic carcinoma of the external auditory canal.

Methods: Seventeen patients with adenoid cystic carcinoma of external auditory canal who had been admitted to a single institution from January 2008 to March 2019 were recruited and retrospectively reviewed. Among patients with T1 tumors, 2 underwent local external auditory canal resection, 1 received lateral temporal bone resection+superficial parotidectomy. Among patients with T2 tumors, all 5 patients underwent lateral temporal bone resection+superficial parotidectomy. Among patients with T3 tumors, 3 underwent subtotal temporal bone resection+superficial parotidectomy, 2 underwent subtotal temporal bone resection+superficial parotidectomy+radiotherapy, and 1 underwent extended temporal bone resection+superficial parotidectomy+radiotherapy. Among patients with T4 tumors, 2 underwent subtotal temporal bone resection+superficial parotidectomy and 1 underwent extended temporal bone resection+total parotidectomy+radiotherapy.

Results: The common manifestations included otalgia (82.4%), hearing loss (23.5%), external auditory canal mass (23.5%), otorrhea (17.6%), and aural fullness (5.9%). In the study, 5/17 (29.4%) patients had been misdiagnosed preoperatively, 5/17 (29.4%) patients revealed local recurrence, and 3/17 patients (17.6%) were identified with distant metastasis postoperatively. The 3- and 5-year overall survival rates were 88.2% and 82.3%, respectively. There was no significant difference in overall survival (P=.746) and disease-free survival (P=.933) between patients receiving different surgical approaches. Three out of 17 patients (17.6%) died of T2, T3, and T4 diseases, respectively.

Conclusion: Otalgia is the most common manifestation of adenoid cystic carcinoma of the external auditory canal, and misdiagnosis is frequently encountered. Surgery is the preferred therapy, and local resection is associated with relapse, lateral temporal bone resection is strongly recommended in patients with early-stage tumor. Regular follow-up should be routinely conducted postoperatively to early identify local recurrence.

Abstract Image

Abstract Image

Abstract Image

外耳道腺样囊性癌预后的研究。
背景:外耳道腺样囊性癌是一种罕见的原发性恶性肿瘤,手术是主要的治疗策略。本研究旨在优化外耳道腺样囊性癌的治疗策略,改善其预后。方法:回顾性分析2008年1月至2019年3月在同一医院收治的17例外耳道腺样囊性癌患者。T1肿瘤患者中2例行局部外耳道切除术,1例行颞外侧骨切除术+腮腺浅表切除术。T2肿瘤患者中,5例均行颞骨外侧切除术+腮腺浅表切除术。T3肿瘤患者中,3例行颞骨次全切除术+腮腺浅表切除术,2例行颞骨次全切除术+腮腺浅表切除术+放疗,1例行颞骨扩展切除术+腮腺浅表切除术+放疗。T4肿瘤患者中,2例行颞骨次全切除术+腮腺浅表切除术,1例行颞骨扩大切除术+腮腺全切除术+放疗。结果:常见表现为耳痛(82.4%)、听力损失(23.5%)、外耳道肿块(23.5%)、耳漏(17.6%)、耳充盈(5.9%)。本研究中,5/17(29.4%)患者术前误诊,5/17(29.4%)患者局部复发,3/17(17.6%)患者术后发现远处转移。3年和5年总生存率分别为88.2%和82.3%。不同手术入路患者的总生存期(P=.746)和无病生存期(P=.933)无显著差异。17例患者中有3例(17.6%)分别死于T2、T3和T4疾病。结论:耳痛是外耳道腺样囊性癌最常见的表现,易误诊。手术是首选的治疗方法,局部切除与复发有关,强烈建议对早期肿瘤患者行颞骨外侧切除术。术后应常规随访,及早发现局部复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
94
审稿时长
6-12 weeks
期刊介绍: The Journal of International Advanced Otology (IAO – Citation Abbreviation: J Int Adv Otol) is an open access double-blind peer-reviewed, international publication. The Journal of International Advanced Otology is fully sponsored and owned by the European Academy of Otology and Neurotology and the Politzer Society. The Journal of International Advanced Otology is published 3 times per year on April, August, December and its publication language is English. The scope of the Journal is limited with otology, neurotology, audiology (excluding linguistics) and skull base medicine. The Journal of International Advanced Otology aims to publish manuscripts at the highest clinical and scientific level. IAO publishes original articles in the form of clinical and basic research, review articles, short reports and a limited number of case reports. Controversial patient discussions, communications on emerging technology, and historical issues will also be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书